Annual Current Ratio
12.38
+2.54+25.81%
31 December 2023
Summary:
Allogene Therapeutics annual current ratio is currently 12.38, with the most recent change of +2.54 (+25.81%) on 31 December 2023. During the last 3 years, it has risen by +3.42 (+38.17%). ALLO annual current ratio is now -24.79% below its all-time high of 16.46, reached on 31 December 2019.ALLO Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
9.35
-2.90-23.67%
30 September 2024
Summary:
Allogene Therapeutics quarterly current ratio is currently 9.35, with the most recent change of -2.90 (-23.67%) on 30 September 2024. Over the past year, it has dropped by -3.23 (-25.68%). ALLO quarterly current ratio is now -57.96% below its all-time high of 22.24, reached on 30 June 2020.ALLO Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.8% | -25.7% |
| 3 y3 years | +38.2% | -0.5% |
| 5 y5 years | -22.1% | -38.8% |
ALLO Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.2% | -26.9% | +15.7% |
| 5 y | 5 years | -24.8% | +38.2% | -58.0% | +15.7% |
| alltime | all time | -24.8% | -58.0% | +503.2% |
Allogene Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 9.35(-23.7%) |
| June 2024 | - | 12.25(-4.3%) |
| Mar 2024 | - | 12.80(+3.4%) |
| Dec 2023 | 12.38(+25.8%) | 12.38(-1.6%) |
| Sept 2023 | - | 12.58(+37.0%) |
| June 2023 | - | 9.18(+13.6%) |
| Mar 2023 | - | 8.08(-17.9%) |
| Dec 2022 | 9.84(0.0%) | 9.84(-15.5%) |
| Sept 2022 | - | 11.64(+1.9%) |
| June 2022 | - | 11.42(-10.4%) |
| Mar 2022 | - | 12.74(+29.5%) |
| Dec 2021 | 9.84 | 9.84(+4.7%) |
| Sept 2021 | - | 9.40(-28.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | 13.09(+0.2%) |
| Mar 2021 | - | 13.06(+45.8%) |
| Dec 2020 | 8.96(-45.6%) | 8.96(-47.4%) |
| Sept 2020 | - | 17.04(-23.4%) |
| June 2020 | - | 22.24(+18.2%) |
| Mar 2020 | - | 18.81(+14.3%) |
| Dec 2019 | 16.46(+3.6%) | 16.46(+7.7%) |
| Sept 2019 | - | 15.28(+13.5%) |
| June 2019 | - | 13.46(-23.0%) |
| Mar 2019 | - | 17.48(+10.0%) |
| Dec 2018 | 15.89(>+9900.0%) | 15.89(+925.2%) |
| Sept 2018 | - | 1.55(-92.2%) |
| June 2018 | - | 19.96 |
| Dec 2017 | 0.00 | - |
FAQ
- What is Allogene Therapeutics annual current ratio?
- What is the all time high annual current ratio for Allogene Therapeutics?
- What is Allogene Therapeutics annual current ratio year-on-year change?
- What is Allogene Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly current ratio year-on-year change?
What is Allogene Therapeutics annual current ratio?
The current annual current ratio of ALLO is 12.38
What is the all time high annual current ratio for Allogene Therapeutics?
Allogene Therapeutics all-time high annual current ratio is 16.46
What is Allogene Therapeutics annual current ratio year-on-year change?
Over the past year, ALLO annual current ratio has changed by +2.54 (+25.81%)
What is Allogene Therapeutics quarterly current ratio?
The current quarterly current ratio of ALLO is 9.35
What is the all time high quarterly current ratio for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly current ratio is 22.24
What is Allogene Therapeutics quarterly current ratio year-on-year change?
Over the past year, ALLO quarterly current ratio has changed by -3.23 (-25.68%)